Answers are grounded in this paper and cite their sources.
Typically, the in situ encapsulation of enzymes within covalent organic frameworks (COFs) is confined to aqueous media under mild conditions, which limits the structural diversity of the host frameworks. To address this limitation, we developed a mild and acid-catalyst-free in situ encapsulation strategy for cellulase (Cel) using an all-natural menthol/thymol deep eutectic solvent (DES) as the reaction medium. Specifically, the co-condensation of 1,3,5-tris(4-aminophenyl)benzene (TAPB) with two aldehyde monomers, 2,5-dihydroxyterephthalaldehyde (DHA) and 2,5-dimethoxyterephthalaldehyde (DMTP), bearing contrasting hydrophilic–hydrophobic properties, enabled precise modulation of the pore wall microenvironment, and notably, the optimal DHA/DMTP ratio of 6:4 produced a synergistic pore microenvironment that was closely associated with a 1.4-fold enhancement in enzymatic activity. As a result, the Cel@TAPB-DHA-DMTP biocomposite delivered an immobilization efficiency of 89.2% while retaining 97.5% relative activity, and retained 62.1% of its initial activity after five consecutive hydrolysis cycles. Importantly, the generality of this strategy was demonstrated across six additional COF systems, where substantial enzyme loadings of 56.2–83.9% were achieved despite their pore apertures being far smaller than the 18 nm molecular dimensions of cellulase, providing compelling evidence for the in situ encapsulation mechanism. Overall, our strategy offers a general and relatively mild platform for fabricating high-performance enzyme–COF biocomposites with tailorable microenvironments, avoiding the use of acid catalysts and harsh conditions.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: